Literature DB >> 12512250

New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers.

Antonio Addis1, Nicola Magrini.   

Abstract

Mesh:

Year:  2002        PMID: 12512250     DOI: 10.1002/pds.785

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  4 in total

Review 1.  Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece.

Authors:  E Karampli; K Souliotis; N Polyzos; J Kyriopoulos; E Chatzaki
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

2.  Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China.

Authors:  Xinyu Zhao; Min Li; Hao Wang; Xiaoqian Xu; Xiaoning Wu; Yameng Sun; Canjian Ning; Bingqiong Wang; Shuyan Chen; Hong You; Jidong Jia; Yuanyuan Kong
Journal:  J Clin Transl Hepatol       Date:  2022-06-21

3.  Performance of a pharmaceutical services regionalization strategy policy in Minas Gerais, Brazil: Pre-post analysis from ERAF project.

Authors:  Tatiana Chama Borges Luz; Ana Karine Sarvel de Castro; Isabela Cristina Marques; Betania Barros Cota; Jèssica de Castro Alves; Michael Robert Law
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

4.  Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study.

Authors:  Xiaodong Guan; Haishaerjiang Wushouer; Mingchun Yang; Sheng Han; Luwen Shi; Dennis Ross-Degnan; Anita Katharina Wagner
Journal:  BMJ Open       Date:  2019-11-28       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.